Basic information Safety Related Supplier

ChemicalBook Product Catalog API Antiparasitic drugs Antiamoebic and anti-trichomoniasis drugs Flubendazole

1/1

Flubendazole NEW

$ 50.00 /100mg

Min. Order
Purity99.67%
Cas No31430-15-6
Supply Ability10g
Update time2025-04-27

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

VIP2Y

United States

United States

show more

Enterprise Verified

Business Bank account Basic Contact Infomation Business Address Trade Company

Chemical Properties

Product Name	Flubendazole
CAS No	31430-15-6
EC-No
Min. Order
Purity	99.67%
Supply Ability	10g
Release date	2025/04/27

Product Introduction

Bioactivity

Name	Flubendazole
Description	Flubendazole (Flumoxane) is available OTC in Europe that is an anthelmintic using to treat worm infection in humans.
In vitro	Flubendazole results in morphological changes included contraction of the soma region, the formation of blebs on the tegument, rostellar disorganization, loss of hooks and destruction of microtriches in Echinococcus granulosus. Flubendazole has a bicyclic ring system in which a benzene has been fused to the -4 and -5 positions of the heterocycle (imidazole). Flubendazole and Albendazole show similar potency in affecting rat embryonic development in vitro, inducing retardation of growth and dysmorphogenic effects at concentrations ≥0.5 μg/mL.
In vivo	Flubendazole (6.32 mg/kg/day) initially induces an arrest of embryonic development followed by a generalized cell death that leads to 100% embryolethality by gestation day (GD) 12.5. Flubendazole (3.46 mg/kg/day) markedly reduces embryonic development by GD 12.5 without causing cell death. Flubendazole in olive oil causes a statistically significant increase in embryolethality at doses of 7.83 mg/kg per day and higher, with complete resorption in all dams at 31.33 mg/kg per day in rats. Flubendazole treatment causes a slight increase of metyrapone and daunorubicin activities in hepatic as well as intestinal cytosol in birds. Flubendazole treatment leads to statistically significant inhibition of intestinal GST activity. Flubendazole treatment leads to slight but significant inhibition (decrease to 69%) of 7-ethoxyresorufin activity in hepatic microsomes.
Storage	keep away from direct sunlight \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 9 mg/mL (28.73 mM), Sonication is recommended.
Keywords	Parasite \| NSC-313680 \| NSC313680 \| MicrotubuleAssociated \| Microtubule/Tubulin \| Microtubule Associated \| microtubule \| Inhibitor \| inhibit \| Flubendazole \| Apoptosis
Inhibitors Related	Stavudine \| 5-Fluorouracil \| Acetylcysteine \| Kojic acid \| Sodium 4-phenylbutyrate \| Urethane \| L-Ascorbic acid \| Hydroxychloroquine \| L-Glutamic acid \| Doxycycline \| Tributyrin \| L-Ascorbic acid sodium salt
Related Compound Libraries	Anti-Parasitic Compound Library \| Target-Focused Phenotypic Screening Library \| Bioactive Compound Library \| Drug Repurposing Compound Library \| Microtubule-Targeted Compound Library \| Anti-Cancer Approved Drug Library \| Anti-Aging Compound Library \| Immunology/Inflammation Compound Library \| Bioactive Compounds Library Max \| Cytoskeletal Signaling Pathway Compound Library \| Anti-Cancer Active Compound Library \| Anti-Cancer Drug Library

show more

Company Profile Introduction

You may like

Recommended supplier

$50.00/100mg

TargetMol Chemicals Inc.

VIP6Y

$50.00/100mg

TargetMol Chemicals Inc.

VIP4Y

$0.00/1kg

Shaanxi Xianhe Biotech Co., Ltd

VIP2Y

$0.00/1kg

Wuhan Biocar Pharmacy CO.,Ltd.

$150.00/1kg

Hebei Zhuanglai Chemical Trading Co Ltd

$10.00/25kg

Hebei Chuanghai Biotechnology Co., Ltd

VIP8Y

$0.00/1KG

Hebei Chuanghai Biotechnology Co., Ltd

$100.00/1KG

Hebei Chuanghai Biotechnology Co,.LTD

VIP5Y

Flubendazole EP

$0.00/25kg

PUSHAN INDUSTRIAL (SHAANXI) CO.,LTD

$15.00/1kg

Ouhuang Engineering Materials (Hubei) Co., Ltd

Send Inquriy